Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Transaction Highlights TPL Group/PTSC

Transaction Highlights TPL Group/PTSC

posted on Sep 03, 2007 01:58AM

Transaction Highlights

Successful culmination of Relational’s efforts on behalf of The TPL Group (“TPL”) to reach mutually beneficial commercialization and licensing agreements in connection with the unification of a microprocessor patent portfolio.

Relational advised TPL on negotiations with Patriot Scientific Corporation (“Patriot”) (OTCBB: PTSC) to unify the microprocessor patent portfolio thereby creating value for TPL and value for Patriot shareholders.

Assisted TPL by balancing and meeting the needs of several constituents

Patriot share price rose substantially upon announcement of the agreement

Reinforces Relational Advisors’ position as a leading financial advisor.

Highlights Relational’s expertise in complex shareholder matters

Accomplished a highly satisfactory agreement for all parties

Relational established a trusted advisor relationship with our client

Client Testimonial

”Relational Advisors was instrumental in enabling TPL and Patriot Scientific to achieve a mutually beneficial agreement. From the time we engaged Relational Advisors in October 2004 through closing, senior professionals provided sage advice that facilitated negotiations and the resolution of sensitive matters. Relational’s expertise far exceeded our expectations. We are extremely satisfied with the outcome.”

Dan Leckrone, Chairman, TPL Group

http://www.raca.com/email/061605/

Share
New Message
Please login to post a reply